[Pleiotrophic peroxisome induction by hypolipidemic agents in primates and rodents].

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Wiener Klinische Wochenschrift

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 8835431
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Comparative studies on the influence of different fibrates on serum lipoproteins in endogenous hyperlipoproteinaemia

  2004cited by this paper
• Differential Induction of Peroxisomal Enzymes by Hypolipidaemics in Human (HepG2) and Rat (MH1C1) Hepatoma Cell Lines

  1995cited by this paper
• Comparative effects of clofibrate on peroxisomal enzymes of human (Hep EBNA2) and rat (FaO) hepatoma cell lines.

  1995cited by this paper
• The Human Peroxisome Proliferator-activated Receptor (PPAR) Subtype NUC1 Represses the Activation of hPPARα and Thyroid Hormone Receptors (*)

  1995cited by this paper
• Peroxisomal lipid metabolism.

  1994cited by this paper
• cDNA cloning of the human peroxisomal enoyl-CoA hydratase: 3-hydroxyacyl-CoA dehydrogenase bifunctional enzyme and localization to chromosome 3q26.3-3q28: a free left Alu Arm is inserted in the 3' noncoding region.

  1994cited by this paper
• Lack of peroxisome proliferation in marmoset liver following treatment with ciprofibrate for 3 years.

  1994cited by this paper
• The peroxisome proliferator-activated receptor interacts with the retinoid X receptor in vivo.

  1994cited by this paper
• Cross-talk among ROR alpha 1 and the Rev-erb family of orphan nuclear receptors.

  1994cited by this paper
• The effects of clofibrate and bezafibrate on cholesterol metabolism in the liver of the male rat

  1994cited by this paper
• Human and rat peroxisome proliferator activated receptors (PPARs) demonstrate similar tissue distribution but different responsiveness to PPAR activators.

  1994cited by this paper
• NER, a new member of the gene family encoding the human steroid hormone nuclear receptor.

  1994cited by this paper
• Cetaben and fibrates both influence the activities of peroxisomal enzymes in different ways.

  1994cited by this paper
• Estimation of peroxisomal beta-oxidation in rat heart by a direct assay of acyl-CoA oxidase.

  1994cited by this paper
• The retinoid X receptor enhances the function of the peroxisome proliferator activated receptor.

  1993cited by this paper
• Positive regulation of the peroxisomal β‐oxidation pathway by fatty acids through activation of peroxisome proliferator‐activated receptors (PPAR)

  1993cited by this paper
• Stimulation of peroxisomal palmitoyl‐CoA oxidase activity by ciprofibrate in hepatic cell lines: Comparative studies in Fao, MH1C1 and HepG2 cells

  1993cited by this paper
• Peroxisomal disorders. Neurodevelopmental and biochemical aspects.

  1993cited by this paper
• Fraudulent (and non fraudulent) fatty acids for human health

  1993cited by this paper
• cDNA cloning, chromosomal mapping, and functional characterization of the human peroxisome proliferator activated receptor.

  1993cited by this paper
• [Risk factors of atherosclerosis--primary examination of Vienna employees].

  1992cited by this paper
• Control of the peroxisomal beta-oxidation pathway by a novel family of nuclear hormone receptors.

  1992cited by this paper
• Identification of a new member of the steroid hormone receptor superfamily that is activated by a peroxisome proliferator and fatty acids.

  1992cited by this paper
• Fatty acids activate a chimera of the clofibric acid-activated receptor and the glucocorticoid receptor.

  1992cited by this paper
• An overview of peroxisome proliferator-induced hepatocarcinogenesis.

  1991cited by this paper
• Two cis-acting regulatory sequences in the peroxisome proliferator-responsive enhancer region of rat acyl-CoA oxidase gene.

  1991cited by this paper
• Mechanisms of lipid-lowering agents.

  1991cited by this paper
• Effects of N-3 fatty acids on lipid metabolism.

  1990cited by this paper
• Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B.

  1990cited by this paper
• Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators

  1990cited by this paper
• Dietary influences on serum lipids and lipoproteins.

  1990cited by this paper
• Comparative studies on nafenopin-induced hepatic peroxisome proliferation in the rat, Syrian hamster, guinea pig, and marmoset.

  1989cited by this paper
• Biochemical mechanisms of induction of hepatic peroxisome proliferation.

  1989cited by this paper
• Effects of fibrates on serum lipids and atherosclerosis.

  1988cited by this paper
• The effect of peroxisome proliferators on microsomal, peroxisomal, and mitochondrial enzyme activities in the liver and kidney.

  1987cited by this paper
• Peroxisomal oxidation of lignoceric acid in rat brain

  1986cited by this paper
• Reduction of plasma lipids, lipoproteins, and apoproteins by dietary fish oils in patients with hypertriglyceridemia.

  1986cited by this paper
• [The contribution of peroxisomes to lipid metabolism].

  1986cited by this paper
• Prevalence and prognostic significance of hypercholesterolemia in men with hypertension. Prospective data on the primary screenees of the Multiple Risk Factor Intervention Trial.

  1986cited by this paper
• Comparison of effects of dietary saturated, monounsaturated, and polyunsaturated fatty acids on plasma lipids and lipoproteins in man.

  1985cited by this paper
• The mitochondrial and peroxisomal pathways of fatty acid oxidation in rat liver.

  1983cited by this paper
• Relationship between morphological changes and lipid-lowering action of p-chlorphenoxyisobutyric acid (CPIB) on hepatic mitochondria and peroxisomes in man.

  1983cited by this paper
• Carcinogenesis by hepatic peroxisome proliferators: evaluation of the risk of hypolipidemic drugs and industrial plasticizers to humans.

  1983cited by this paper
• Evaluation of Selected Hypolipidemic Agents for the Induction of Peroxisomal Enzymes and Peroxisome Proliferation in the Rat Liver

  1983cited by this paper
• Cetaben versus clofibrate: comparison of toxicity and peroxisome proliferation in rats.

  1983cited by this paper
• Individual peroxisomal beta-oxidation enzymes.

  1982cited by this paper
• Regulation of hepatic fatty acid oxidation and ketone body production.

  1980cited by this paper
• Properties of hypolipidemic peroxisome proliferators in the lymphocyte [3H]thymidine and Salmonella mutagenesis assays.

  1980cited by this paper
• A fatty acyl-CoA oxidizing system in rat liver peroxisomes; enhancement by clofibrate, a hypolipidemic drug.

  1976cited by this paper
• Effects of polyunsaturated fats on lipid metabolism in patients with hypertriglyceridemia.

  1975cited by this paper

• No citing papers are available for this paper.